Clinical trial
Hearing Intervention for Patients With Early-Stage Alzheimer's Disease: Determining the Benefits for Patients and Family Caregivers
NCT02294513 is registered in ClinicalTrials.gov with Phonak AG, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hearing Intervention for Patients With Early-Stage Alzheimer's Disease: Determining the Benefits for Patients and Family Caregivers
- Lead sponsor
- Phonak AG, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- February 28, 2017
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.